Peanut allergy associated with vaccinations leads to profit for patch-peddling pharmaceutical company

A French pharmaceutical company is hoping to reap massive profits from a new drug patch that it says treats a common food allergy caused by vaccines. The DBV Technologies SA Viaskin Peanut patch for peanut allergy currently holds a market value of $1 billion, according to reports, which represents yet another major profit stream for an industry that creates many of the diseases it treats.

Read full story here: Peanut allergy associated with vaccinations leads to profit for patch-peddling pharmaceutical company – NaturalNews.com

Please follow and like us:

Related Post

Leave a Reply